SOD1 and amyotrophic lateral sclerosis: Moreover, considering that SOD1 mutations were found in up to 4% sALS cases5 and that SOD1 pathology is found in part of sporadic ALS patients48–50, our compounds likely to have therapeutic potential for at least some of the sporadic ALS cases too.